Valuation : Celltrion, Inc.

Market Cap 44,712B 32.92B 28.4B 26.75B 24.38B 45.56B 3,110B 45.91B 317B 123B 1,590B 124B 121B 5,223B P/E 2026 *
28.3x
P/E 2027 * 24.5x
Enterprise Value 46.91B 34.54M 29.8M 28.07M 25.58M 47.8M 3.26B 48.16M 332M 129M 1.67B 130M 127M 5.48B EV / Sales 2026 *
8.56x
EV / Sales 2027 * 7.33x
Free-Float
60.59%
Yield 2026 *
0.41%
Yield 2027 * 0.44%
1 day-0.90%
1 week-3.67%
Current month-1.38%
1 month-0.21%
3 months+4.11%
6 months-17.98%
Current year+8.07%
1 week 184,200
Extreme 184200
191,300
1 month 180,300
Extreme 180300
212,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,247.57
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 51 2026-02-12
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 Sell 500 0.0002%
1/16/26 Sell 1,000 0.0004%
1/16/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.90%-3.67%+14.26%+48.44% 32.92B
-0.10%-0.92%+2.17%+17.71% 50.14B
-0.30%-2.88%+429.29%+496.95% 44.85B
+2.13%+0.89%+43.59%+17.61% 43.43B
+0.87%-3.73%+8.96%+73.17% 41.14B
+2.71%+6.82% - - 17.56B
+1.68%-4.20%+25.28%+116.83% 16.55B
+0.88%+0.58%+16.80%+29.22% 14.65B
+3.34%-1.13%+80.94%+39.19% 13.93B
-0.97%-5.38%-10.12%-39.15% 12.33B
Average +0.93%-1.30%+67.91%+88.88% 28.75B
Weighted average by Cap. +0.71%-1.39%+88.02%+114.73%

Financials

2026 *2027 *
Net sales 5,480B 4.04B 3.48B 3.28B 2.99B 5.58B 381B 5.63B 38.83B 15.07B 195B 15.15B 14.82B 640B 6,294B 4.63B 4B 3.77B 3.43B 6.41B 438B 6.46B 44.59B 17.3B 224B 17.4B 17.02B 735B
Net income 1,511B 1.11B 960M 904M 824M 1.54B 105B 1.55B 10.7B 4.15B 53.73B 4.18B 4.09B 176B 1,763B 1.3B 1.12B 1.06B 961M 1.8B 123B 1.81B 12.49B 4.85B 62.71B 4.88B 4.77B 206B
Net Debt 2,199B 1.62B 1.4B 1.32B 1.2B 2.24B 153B 2.26B 15.58B 6.04B 78.19B 6.08B 5.95B 257B 1,409B 1.04B 895M 843M 768M 1.44B 98.01B 1.45B 9.98B 3.87B 50.11B 3.9B 3.81B 165B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
26-09-02 ₩186,300.00 -0.90% 299,403
26-09-01 ₩188,000.00 -0.48% 268,440
26-08-31 ₩188,900.00 -0.94% 643,636
26-08-28 ₩190,700.00 -0.31% 375,920
26-08-27 ₩191,300.00 -1.09% 255,697
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
186,300.00KRW
Average target price
266,031.64KRW
Spread / Average Target
+42.80%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock